GlassScriptPhysician profile
Youngun Suh
NPI 1346498870
$3,986.53
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,063 · 2022: $887 · 2023: $661 · 2024: $376.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,036.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,036.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,159.93 | 2021-2024 | Superion Indirect Decompression System |
| Vertos Medical, INC. | $432.03 | 2022-2024 | Mild Device Kit |
| Painteq LLC | $314.92 | 2021-2024 | Painteq |
| Abbott Laboratories | $226.07 | 2021-2023 | Proclaim |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $146.07 | 2021-2023 | Relistor |
| Abbvie INC. | $129.90 | 2023-2024 | |
| Medtronic, INC. | $98.50 | 2022-2023 | Intellis Adaptivestim |
| Relievant Medsystems, INC. | $81.68 | 2023 | Intracept |
| Saluda Medical Americas, INC. | $69.85 | 2023-2024 | Evoke Scs, Evoke |
| Spinal Simplicity, LLC | $65.61 | 2022 | |
| Valinor Pharma, LLC | $57.18 | 2023 | Movantik |
| Redhill Biopharma INC. | $39.48 | 2021 | |
| Ibsa Pharma INC. | $36.52 | 2023 | Tirosint, Licart |
| Teva Pharmaceuticals USA, INC. | $28.56 | 2021 | |
| Grt US Holding, INC. | $27.06 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $24.99 | 2021 | |
| Scilex Pharmaceuticals INC. | $24.82 | 2023 | Ztlido |
| Nalu Medical, INC. | $23.36 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Youngun Suh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.